InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
44%
T+90 mean return
-3.9%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by BURZIK CATHERINE M, Director. Director active across 4 companies, notably Orthofix Medical Inc.. In total, 20 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €88k. History available since 21 June 2021. The latest transaction was filed on 28 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations20 total
930 shares0Common StockSEC:0001062993-25-001305:0
47,486 shares@ US$14.2387.6% of flowCommon StockSEC:0000950170-24-043032:0
923 shares0Common StockSEC:0001062993-24-001292:0
900 shares0Common StockSEC:0001062993-24-001295:0
120,676 shares0Common StockSEC:0001209191-23-052978:0
3,589 shares0Common StockSEC:0001209191-23-038789:0
14,354 shares0Common StockSEC:0001209191-23-008138:0
848 shares0Common StockSEC:0001062993-23-001429:0
14,052 shares0Common StockSEC:0001209191-23-002645:0
2,730 sharesCommon StockSEC:0001127602-22-020696:0
8,844 shares0Common StockSEC:0001209191-22-035049:0
820 shares0Common StockSEC:0001062993-22-001643:0
820 shares0Common StockSEC:0001062993-22-001643
1,660 shares@ US$30.276.2% of flowCommon StockSEC:0001209191-21-065776
Ideal exit: 16 Aug 2022 (T+270)
1,660 shares@ US$30.270.0073% mcap50.0% of flowCommon StockSEC:0001209191-21-065776:0
Ideal exit: 16 Aug 2022 (T+270)
3,077 sharesCommon StockSEC:0001127602-21-023391:0
3,077 sharesCommon StockSEC:0001127602-21-023391
5,976 shares0Common StockSEC:0001209191-21-042755
5,976 shares0Common StockSEC:0001209191-21-042755:0
1,267 sharesCommon StockSEC:0001543407-16-000089:0
20 of 20 declarations
About BURZIK CATHERINE M
Catherine M. Burzik is a Director of Orthofix Medical Inc., Haemonetics Corp, and Becton Dickinson & Co. As a board member, she participates in overseeing the companies' activities and making strategic decisions. Her experience and skills in corporate governance are essential for guiding these companies in their growth and innovation objectives.
